Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan D Zurawski, M.D.

Profile Picture

Associate Neurologist
Brigham & Women's Hospital Department of Neurology/Partners Multiple Sclerosis Center
Harvard Medical School Instructor of Neurology

Multiple Sclerosis Fellowship
Clinical Fellow in Multiple Sclerosis, Partners MS Center/Brigham & Women's Hospital
2016 – 2018

Neurology Residency
Harvard Medical School/Beth Israel Deaconess Medical Center
2013 – 2016

Internship in Medicine
Georgetown University/Medstar Washington Hospital
2012 – 2013

Georgetown University School of Medicine
Doctor of Medicine (M.D.)
2008 – 2012

Cornell University
Bachelor of Arts (B.A.)

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T. Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Mult Scler Relat Disord. 2022 Nov; 67:104079. PMID: 35952457; PMCID: PMC9330583.
    Citations:    Fields:    
  2. Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK. COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Mult Scler Relat Disord. 2022 Jul; 63:103946. PMID: 35709663; PMCID: PMC9556032.
    Citations:    Fields:    Translation:Humans
  3. Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series. Mult Scler Relat Disord. 2022 Jul; 63:103861. PMID: 35576727.
    Citations:    Fields:    Translation:HumansCells
  4. Healy BC, Zurawski J, Chitnis T, Weiner HL, Glanz BI. Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis. Qual Life Res. 2022 Jun; 31(6):1799-1805. PMID: 34783972.
    Citations: 2     Fields:    Translation:Humans
  5. Glanz BI, Zurawski J, Casady EC, Shamah R, Weiner M, Chitnis T, Weiner HL, Healy BC. The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Apr-Jun; 7(2):20552173211007523. PMID: 34046184; PMCID: PMC8138295.
    Citations: 1     
  6. Zurawski J, Healy BC, Ratajska A, Barker L, Glanz BI, Houtchens M. Identification of a predominant cognitive phenotype in patients with multiple sclerosis. Eur J Neurol. 2020 06; 27(6):1083-1088. PMID: 32080929.
    Citations: 2     Fields:    Translation:Humans
  7. Glanz BI, Zurawski J, Gonzalez CT, Shamah R, Ratajska A, Chitnis T, Weiner HL, Healy BC. Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosis. Mult Scler Relat Disord. 2020 May; 40:101944. PMID: 32007653.
    Citations: 1     Fields:    Translation:Humans
  8. Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler. 2020 02; 26(2):177-187. PMID: 31714181.
    Citations: 15     Fields:    Translation:Humans
  9. Ratajska A, Zurawski J, Healy B, Glanz BI. Computerized Cognitive Behavioral Therapy for Treatment of Depression in Multiple Sclerosis: A Narrative Review of Current Findings and Future Directions. Int J MS Care. 2019 May-Jun; 21(3):113-123. PMID: 31191176; PMCID: PMC6552991.
    Citations: 2     
  10. Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. J Neurol Sci. 2019 Aug 15; 403:38-43. PMID: 31207364.
    Citations: 3     Fields:    Translation:Humans
  11. Zurawski J, Glanz BI, Chua A, Lokhande H, Rotstein D, Weiner H, Engler D, Chitnis T, Healy BC. Time between expanded disability status scale (EDSS) scores. Mult Scler Relat Disord. 2019 May; 30:98-103. PMID: 30763908.
    Citations: 5     Fields:    Translation:Humans
  12. Zurawski J, Stankiewicz J. Corrigendum to Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts. Am J Med. 2018 Dec; 131(12):1528. PMID: 30509389.
    Citations:    Fields:    
  13. Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis. Mult Scler. 2019 11; 25(13):1791-1799. PMID: 30381985.
    Citations: 4     Fields:    Translation:Humans
  14. Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate. J Neurol Sci. 2018 11 15; 394:127-131. PMID: 30248571.
    Citations: 2     Fields:    Translation:Humans
  15. Zurawski J, Stankiewicz J. Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts. Am J Med. 2018 05; 131(5):464-472. PMID: 29274753.
    Citations: 5     Fields:    Translation:Humans
  16. Zurawski J, Lassmann H, Bakshi R. Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review. JAMA Neurol. 2017 Jan 01; 74(1):100-109. PMID: 27893883.
    Citations: 27     Fields:    Translation:Humans
  17. Zurawski J, Flinn A, Sklover L, Sloane JA. Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors. J Neurol. 2016 Aug; 263(8):1511-7. PMID: 27193310.
    Citations: 3     Fields:    Translation:Humans
  18. Aravamuthan BR, Sánchez Fernández I, Zurawski J, Olson H, Gorman M, Takeoka M. Pediatric anti-Hu-associated encephalitis with clinical features of Rasmussen encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015 Oct; 2(5):e150. PMID: 26445726.
    Citations: 2     Fields:    
  19. Leung LY, Brett M, Zurawski J, Kumar S. Recurrent aseptic meningitis with reversible cerebral vasoconstriction. J Neurol Sci. 2014 Apr 15; 339(1-2):239-40. PMID: 24607332.
    Citations: 1     Fields:    Translation:Humans
  20. Zurawski J, Akhondi H. Tolosa-Hunt syndrome--a rare cause of headache and ophthalmoplegia. Lancet. 2013 Sep 07; 382(9895):912. PMID: 24012271.
    Citations: 6     Fields:    Translation:Humans
  21. Dickson HM, Zurawski J, Zhang H, Turner DL, Vojtek AB. POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66. J Neurosci. 2010 Oct 06; 30(40):13319-25. PMID: 20926658.
    Citations: 22     Fields:    Translation:AnimalsCells
  22. Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, Hu L, Mok SI, Shah A, Savner EM, Tolias C, Corfas R, Chen S, Inquimbert P, Xu Y, McInnes RR, Rice FL, Corfas G, Ma Q, Woolf CJ, Greenberg ME. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron. 2010 Mar 25; 65(6):886-98. PMID: 20346763.
    Citations: 190     Fields:    Translation:AnimalsCells
  23. Taylor J, Chung KH, Figueroa C, Zurawski J, Dickson HM, Brace EJ, Avery AW, Turner DL, Vojtek AB. The scaffold protein POSH regulates axon outgrowth. Mol Biol Cell. 2008 Dec; 19(12):5181-92. PMID: 18829867; PMCID: PMC2592661.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zurawski's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (101)
Co-Authors (23)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.